These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3566313)

  • 21. [Allergologic criticism on the external use of sensitizing drugs].
    Behrbohm P; Lenzner M
    Z Gesamte Hyg; 1971 Nov; 17(11):846-53. PubMed ID: 4259651
    [No Abstract]   [Full Text] [Related]  

  • 22. Maximum flux versus transdermal delivery: comment on Farahmand and Maibach (2009).
    Kissel JC; Bunge AL
    Int J Pharm; 2010 Oct; 398(1-2):247-8. PubMed ID: 20600727
    [No Abstract]   [Full Text] [Related]  

  • 23. Percutaneous drug absorption and administration.
    Choonara I
    Arch Dis Child Fetal Neonatal Ed; 1994 Sep; 71(2):F73-4. PubMed ID: 7979481
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dermatologic agents. I. Skin resorption and skin and mucous membrane disinfection].
    Fröhlich HH
    Pharm Unserer Zeit; 1981 Sep; 10(5):129-44. PubMed ID: 7291215
    [No Abstract]   [Full Text] [Related]  

  • 25. Transdermal drug delivery: past progress, current status, and future prospects.
    Langer R
    Adv Drug Deliv Rev; 2004 Mar; 56(5):557-8. PubMed ID: 15019745
    [No Abstract]   [Full Text] [Related]  

  • 26. Interview with Richard H Guy by Hannah Coaker.
    Guy RH
    Ther Deliv; 2014 Feb; 5(2):123-8. PubMed ID: 24483191
    [No Abstract]   [Full Text] [Related]  

  • 27. [Some data on external therapy of dermatoses].
    Ormea TF
    Minerva Med; 1973 Oct; 64(77):4021-8. PubMed ID: 4764073
    [No Abstract]   [Full Text] [Related]  

  • 28. [Adverse reactions to externally applied drugs].
    Honda M
    Nihon Ika Daigaku Zasshi; 1984 Oct; 51(5):539-43. PubMed ID: 6238977
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study of the percutaneous absorption of antibacterial agents].
    Eperjessy E; Dákay Z; Honti B
    Acta Pharm Hung; 1970 Jan; 40(1):12-6. PubMed ID: 5412630
    [No Abstract]   [Full Text] [Related]  

  • 30. The contributions of the Celtic masters and their associates.
    Moss GP
    Skin Pharmacol Physiol; 2013; 26(4-6):343-55. PubMed ID: 23921121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mathematical and pharmacokinetic modelling of epidermal and dermal transport processes.
    Anissimov YG; Jepps OG; Dancik Y; Roberts MS
    Adv Drug Deliv Rev; 2013 Feb; 65(2):169-90. PubMed ID: 22575500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypersensitivity reactions to products and devices in plastic surgery.
    Cohen DE; Kaufmann JM
    Facial Plast Surg Clin North Am; 2003 May; 11(2):253-65. PubMed ID: 15062278
    [No Abstract]   [Full Text] [Related]  

  • 33. [Contact allergy and photo-allergy to the halogenic bactericides in hygienic products].
    Midana A; Zina G; Bonu G
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(2):249-51. PubMed ID: 4228817
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparison of transdermal permeation in vitro of lidocaine tincture and microemulsion].
    Huang L; Chen ZL; Li GF; Zhu XL; Liu C
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):541-2. PubMed ID: 17545055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cutaneous penetration].
    Jamoulle JC
    Ann Dermatol Venereol; 1988; 115(5):627-40. PubMed ID: 3058009
    [No Abstract]   [Full Text] [Related]  

  • 36. [Nipiopharmacology from the dermatologic pint of view].
    Gomirato Sandrucci M; Bonu G
    Minerva Nipiol; 1968; 18(2):51-60. PubMed ID: 5744924
    [No Abstract]   [Full Text] [Related]  

  • 37. [Preparation of lidocaine nanoemulsion and its transdermal absorption by rat skin ex vivo].
    Zhu XL; Li GF; Zeng K; Cheng ZL
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):451-4. PubMed ID: 20335107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of bioavailability: measurement of absorption through skin in vitro.
    Hotchkiss SA
    Curr Protoc Toxicol; 2001 May; Chapter 5():Unit 5.1.1-14. PubMed ID: 20949434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical penetration enhancers.
    Newton SJ
    Int J Pharm Compd; 2013; 17(5):370-4. PubMed ID: 24459781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical enhancers for transdermal drug transport.
    Bauerová K; Matusová D; Kassai Z
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):85-94. PubMed ID: 11554439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.